Indapamid-Hemihydrat Heumann

Indapamide, the active ingredient in Indapamid-Hemihydrat Heumann, is a thiazide‑like diuretic presented as an oral dosage form for oral use. It is employed to manage elevated blood pressure and fluid retention in adults.

GNH USA supplies Indapamid-Hemihydrat Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide acts on the renal distal convoluted tubule to promote diuresis, making it useful in several cardiovascular‑related conditions. - Hypertension: lowers systolic and diastolic blood pressure by reducing plasma volume and peripheral resistance. - Edema: decreases excess interstitial fluid associated with heart, liver or kidney disease. - Heart failure: assists in controlling fluid overload and improves symptom management.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Increased urination: more frequent need to void due to diuretic action. - Electrolyte imbalance: low potassium or sodium levels may occur. - Headache: mild to moderate pain in the head region. - Nausea: feeling of stomach discomfort or urge to vomit.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss leading to hypotension. - Acute electrolyte disturbances: marked hypokalemia or hyponatremia requiring medical attention. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: evaluate creatinine clearance before and during treatment. - Use caution in gout: diuretic‑induced hyperuricemia may precipitate attacks. - Adjust in hepatic impairment: consider dose reduction in severe liver disease. - Elderly patients: start at lower dose and monitor for orthostatic hypotension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can alter the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - Cyclosporine: combined use can exacerbate nephrotoxicity. - High‑dose NSAIDs: may reduce diuretic efficacy and impair renal function.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: risk of additive blood pressure lowering and hyperkalemia. - Beta‑blockers: may enhance antihypertensive effect, requiring dose adjustment. - Digoxin: altered serum levels may occur, necessitating monitoring. - Corticosteroids: may increase risk of electrolyte disturbances.